AHA and BHA together: the exfoliation combination that works better than either alone for most skin types

The difference between AHA and BHA and why it matters at the pore level

Alpha hydroxy acids (glycolic acid, lactic acid, mandelic acid) are water-soluble exfoliants that work on the skin surface and upper epidermis, breaking the bonds between dead cells and accelerating their shedding. Beta hydroxy acid (salicylic acid is the primary BHA used in skincare) is oil-soluble, which allows it to penetrate into the sebum-filled environment of a pore and exfoliate from inside the pore lining — a location that water-soluble AHAs cannot reach. This functional difference means AHAs primarily address surface texture, pigmentation and dullness, while BHA primarily addresses congestion, blackheads and the type of breakouts driven by sebum accumulation and bacteria in pores. The combination is most relevant for skin with both surface texture concerns and pore congestion, where neither acid alone addresses the full picture.

Why 30 days is the meaningful trial period for chemical exfoliants

The "30 days, 300 miracles" philosophy associated with K-beauty AHA/BHA routines reflects a realistic understanding of skin cell turnover timelines. A single application of an exfoliating acid does not produce dramatic visible results because the skin you are looking at today contains cells that were formed in the basal layer 28 to 40 days ago. The acids work on the cells currently at the surface — and visible improvement in texture, tone and pore appearance reflects the improved production cycle initiated during the previous 28 to 40 days, not the immediate surface action of the most recent application. Evaluating an exfoliant after three or four uses is premature; the meaningful assessment happens at four weeks of twice-daily use.

The correct sequence for AHA and BHA in a routine

When using AHA and BHA as separate products in the same routine, pH and texture determine the optimal sequence. Both AHAs and salicylic acid are most active at low pH (typically 3.0 to 4.0 for AHAs, 3.0 to 4.0 for salicylic acid) — and because the skin's buffering capacity will gradually raise the pH of any acidic product applied to it, applying both sequentially means the second one encounters a slightly raised skin pH. The practical approach is to allow the first exfoliant a few minutes to absorb and do its primary work before applying the second. Alternatively, combination AHA/BHA toners formulated together are optimised by their chemist to function at a single pH appropriate for both actives, removing the timing calculation altogether and usually producing better integration than two separate products.

Managing the purging period and how to distinguish it from breakouts

Chemical exfoliant use frequently triggers a "purging" period in the first two to four weeks — an acceleration of the skin cycle that brings microcomedones (pre-breakouts forming below the surface) to the surface faster than they would have appeared otherwise. This looks like a breakout but consists of pustules and blackheads appearing in areas where the skin was already prone to them, resolving faster than normal breakouts, and followed by clearer skin than was present before starting the exfoliant. True breakouts driven by irritation or product reaction appear in new areas where the skin was not previously prone to congestion, do not resolve quickly, and are associated with redness and sensitisation. Distinguishing between the two is important because purging requires continuing through the discomfort while a true irritation reaction requires stopping immediately.

Some by Mi philosophy: the dermatologist-tested approach to exfoliant safety

SOME BY MI has built its brand identity around dermatologist-tested formulation at concentrations appropriate for home use without professional oversight — lower concentrations of both AHAs and BHA than clinical peels, at pH levels that produce meaningful exfoliation without significantly disrupting the barrier. The thirty-day protocol framing is not marketing but a clinical design decision: at the concentrations used, meaningful visible results require consistent use over a full cell cycle rather than intensive short-term treatment. This consumer-appropriate approach differs from high-street AHA serums at high concentrations that produce faster visible results but with higher irritation potential — the trade-off between speed and tolerability that most home-use skincare must navigate.